Brian Druker, M.D., comments on a new study about the inefficacy of cancer medications, saying, “It becomes a really difficult debate, but one that’s worth having.”

A local OHSU cardiology patient is profiled in a KPTV-TV feature about the American Heart Association’s Heart & Stroke walk.

Legacy Health and the OHSU Health System are working with PacificSource to introduce new health plan product offerings to the market beginning January, 2020.

In a presentation regarding CAR-T treatment, Richard Maziarz, M.D., says hospitals may charge as much as $1.5 million or more to avoid losing money.

Research conducted by OHSU and UC Davis finds that advanced cardiac tests for chest pain should only be done when assessments indicate heart disease is likely.

Techonomy profiles memory chipmaker Micron’s interest in artificial intelligence; Terry Lo, Ph.D., discusses OHSU’s collaboration with the company, which includes efforts to ensure data can be analyzed fast enough to deliver results for cancer patients participating in clinical trials.

A research team led by Vinay Prasad, M.D., M.P.H., finds that cancer drugs granted accelerated approval from the FDA often don’t demonstrate long-term benefits for patients.

New OHSU survey characterizes efforts to reduce opioid use disorder in Coos and other southwest Oregon counties.

OHSU cancer patient is interviewed by KGW after losing his leg due to osteosarcoma. Trail Blazer CJ McCollum sends a video message of support.

The Daily Journal of Commerce names the Knight Cancer Research Building the “DJC TopProjects 2019” first-place winner for health care.